Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georgina Buck

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
British Journal of Haematology|March 14, 2012
Outcomes in older adults with acute lymphoblastic leukaemia (ALL): results from the international MRC UKALL XII/ECOG2993 trialJonathan I Sive, Georgina Buck, Adele Fielding, et al.
Blood|March 25, 2006
Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis: results from the international ALL trial MRC UKALL XII/ECOG E2993Hillard M Lazarus, Susan M Richards, Raj Chopra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 29, 2018
Hydroxycarbamide Plus Aspirin Versus Aspirin Alone in Patients With Essential Thrombocythemia Age 40 to 59 Years Without High-Risk FeaturesAnna L Godfrey, Peter J Campbell, Cathy MacLean, et al.
The New England Journal of Medicine|July 8, 2005
Hydroxyurea compared with anagrelide in high-risk essential thrombocythemiaClaire N Harrison, Peter J Campbell, Georgina Buck, et al.
American Journal of Hematology|July 29, 2016
Delays in postremission chemotherapy for Philadelphia chromosome negative acute lymphoblastic leukemia are associated with inferior outcomes in patients who undergo allogeneic transplant: An analysis from ECOG 2993/MRC UK ALLXIIAnita J Kumar, Phyllis A Gimotty, Joel M Gelfand, et al.
Blood|May 3, 2008
MPL mutations in myeloproliferative disorders: analysis of the PT-1 cohortPhilip A Beer, Peter J Campbell, Linda M Scott, et al.
Blood|August 18, 2005
Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993Jacob M Rowe, Georgina Buck, Alan K Burnett, et al.
Blood|November 27, 2013
UKALLXII/ECOG2993: addition of imatinib to a standard treatment regimen enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukemiaAdele K Fielding, Jacob M Rowe, Georgina Buck, et al.
Blood|October 13, 2006
Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 studyAdele K Fielding, Susan M Richards, Rajesh Chopra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2009
Prognostic implications of NOTCH1 and FBXW7 mutations in adults with T-cell acute lymphoblastic leukemia treated on the MRC UKALLXII/ECOG E2993 protocolMarc R Mansour, Maria L Sulis, Veronique Duke, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
British Journal of Haematology|March 14, 2012
Outcomes in older adults with acute lymphoblastic leukaemia (ALL): results from the international MRC UKALL XII/ECOG2993 trialJonathan I Sive, Georgina Buck, Adele Fielding, et al.
Blood|March 25, 2006
Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis: results from the international ALL trial MRC UKALL XII/ECOG E2993Hillard M Lazarus, Susan M Richards, Raj Chopra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 29, 2018
Hydroxycarbamide Plus Aspirin Versus Aspirin Alone in Patients With Essential Thrombocythemia Age 40 to 59 Years Without High-Risk FeaturesAnna L Godfrey, Peter J Campbell, Cathy MacLean, et al.
The New England Journal of Medicine|July 8, 2005
Hydroxyurea compared with anagrelide in high-risk essential thrombocythemiaClaire N Harrison, Peter J Campbell, Georgina Buck, et al.
American Journal of Hematology|July 29, 2016
Delays in postremission chemotherapy for Philadelphia chromosome negative acute lymphoblastic leukemia are associated with inferior outcomes in patients who undergo allogeneic transplant: An analysis from ECOG 2993/MRC UK ALLXIIAnita J Kumar, Phyllis A Gimotty, Joel M Gelfand, et al.
Blood|May 3, 2008
MPL mutations in myeloproliferative disorders: analysis of the PT-1 cohortPhilip A Beer, Peter J Campbell, Linda M Scott, et al.
Blood|August 18, 2005
Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993Jacob M Rowe, Georgina Buck, Alan K Burnett, et al.
Blood|November 27, 2013
UKALLXII/ECOG2993: addition of imatinib to a standard treatment regimen enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukemiaAdele K Fielding, Jacob M Rowe, Georgina Buck, et al.
Blood|October 13, 2006
Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 studyAdele K Fielding, Susan M Richards, Rajesh Chopra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2009
Prognostic implications of NOTCH1 and FBXW7 mutations in adults with T-cell acute lymphoblastic leukemia treated on the MRC UKALLXII/ECOG E2993 protocolMarc R Mansour, Maria L Sulis, Veronique Duke, et al.
Pageof 4